SCHEMBL19042685

SCHEMBL19042685

CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](c3ccc(N(C)C)cc3)C[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 16/20 1.00
▸ PGR P06401 15/20 1.00
▸ AR P10275 12/20 1.00
▸ CYP2C8 P10632 2/20 1.00
▸ CYP3A4 P08684 3/20 0.55
▸ CYP2D6 P10635 3/20 0.55
▸ CYP2C19 P33261 3/20 0.55
▸ CYP2C9 P11712 3/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ THPO P40225 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ NR1I2 O75469 1/20 0.55
▸ GMNN O75496 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22861552 1.00 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL19042733 1.00 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL20048337 0.92 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL22861542 0.92 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL19042672 0.92 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL22861585 0.91 NR3C1 (1.00) NR3C1PGRARCYP2C8
SCHEMBL22861575 0.91 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL19042675 0.91 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL22861536 0.91 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4
SCHEMBL19042671 0.91 NR3C1 (1.00) NR3C1PGRARCYP2C8CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11208432-B2 Inhibitors of glucocorticoid receptor ORIC PHARMACEUTICALS, INC. (US) 2021-12-28 — — US disclosed
US-20210002324-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2021-01-07 — — US disclosed
WO-2017112909-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. (US) 2017-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11208432-B2 Inhibitors of glucocorticoid receptor NR3C1, NR3C2, MC2R NR3C1 1/4885PGR 61/4885AR 13/4885
US-20210002324-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R NR3C1 1/4885PGR 61/4885AR 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback